Cargando…
Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment
Influenza A viruses are important human and animal pathogens. Seasonal influenza viruses cause infections every year, and occasionally zoonotic viruses emerge to cause pandemics with significantly higher morbidity and mortality rates. Three cases of laboratory confirmed human infection with avian in...
Autores principales: | Wolf, Stefan, Johnson, Scott, Perwitasari, Olivia, Mahalingam, Suresh, Tripp, Ralph A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382437/ https://www.ncbi.nlm.nih.gov/pubmed/28435679 http://dx.doi.org/10.1038/cti.2017.8 |
Ejemplares similares
-
MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication
por: Wolf, Stefan, et al.
Publicado: (2016) -
Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway
por: Yuan, Shi‐guo, et al.
Publicado: (2022) -
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties
por: Shen, Zongshan, et al.
Publicado: (2020) -
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012) -
The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
por: Grassia, Gianluca, et al.
Publicado: (2009)